Crsp stock forecast 2025.

Nov 11, 2023 · CRISPR Therapeutics AG (CRSP) share price prediction for 2023, 2024, 2025, 2026 and 2027. CRSP one year forecast. CRISPR Therapeutics AG stock monthly and weekly ... Find real-time UBER - Uber Technologies Inc stock quotes, company profile, news and forecasts from CNN Business.CRISPR Therapeutics (CRSP) stock forecast for 2025 Last update: November 21, 2023 (07:48) Sector: Healthcare The share price of CRISPR Therapeutics AG (CRSP) now CRISPR Therapeutics AG 69.97 D 0.74% (0.52) What analysts predict: $87.78 52-week High/Low: $76.19 / $37.55 50/200 Day Moving Average: $46.64 / $51.55CRISPR Therapeutics last issued its quarterly earnings data on November 6th, 2023. The reported ($1.41) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($2.04) by $0.63. CRISPR Therapeutics has generated ($4.47) earnings per share over the last year ( ($4.47) diluted earnings per share).CRSP stock extended its rally from levels of around $107 in mid-November 2020 to $161 currently. Also, the stock has rallied a stellar 5x from levels of $34 in late March 2020 – when markets ...

The latest CRISPR Therapeutics stock prices, stock quotes, news, and CRSP history to help you invest and trade smarter. ... The 68 analysts offering price forecasts for CRISPR Therapeutics have a ...

Stock Price Forecast. The 5 analysts offering 12-month price forecasts for Danimer Scientific Inc have a median target of 3.00, with a high estimate of 3.75 and a low estimate of 2.00. The median ...

Microsoft Corp Revenue Forecast for 2023 - 2025 - 2030. In the last four years, Microsoft Corp's Revenue has grown by 57.55%, rising from $125.84B to $198.27B. For next year, analysts predict Revenue of $257.87B, which would mean an increase of 30.06%. Over the next seven years, experts predict that Microsoft Corp's Revenue will …Wall Street Stock Market & Finance report, prediction for the future: You'll find the Editas Medicine share forecasts, stock quote and buy / sell signals below. According to present data Editas Medicine's EDIT shares and potentially its market environment have been in a bullish cycle in the last 12 months (if exists). Intellia Therapeutics (NTLA) stock price prediction is 94.108148888185 USD. The Intellia Therapeutics stock forecast is 94.108148888185 USD for 2024 November 30, Saturday; and 452.939 USD for 2028 November 30, Thursday with technical analysis.Shares of CRISPR Therapeutics ( CRSP -0.74%) sank 50.5% in 2021, according to data from S&P Global Market Intelligence. After surging roughly 151% across 2020's trading, investors reassessed the ...Financial traders can chatter all they want about Apple's earnings miss, but there's data indicating strong upside potential for AAPL stock. A rare earnings miss for Apple doesn't mean you should dump AAPL stock Source: Vytautas Kielaitis /...

About the Square, Inc. stock forecast. As of 2023 December 03, Sunday current price of SQ stock is 65.040$ and our data indicates that the asset price has been in an uptrend for the past 1 year (or since its inception).. Block Inc - Class A stock price as been showing a rising tendency so we believe that similar market segments were very …

Despite the pain today, there are a handful of Cathie Wood stocks that could double by 2025. Here are three of them. Despite the pain today, there are a handful of intriguing Cathie Wood stocks Source: rhendrikdwenz via Shutterstock It’s be...

For Editas Medicine stock forecast for 2031, 12 predictions are offered for each month of 2031 with average Editas Medicine stock forecast of $8.2, a high forecast of $8.21, and a low forecast of $8.19. The average Editas Medicine stock forecast 2031 represents a 4.21% increase from the last price of $7.86999988555908.Find real-time NOK - Nokia Oyj stock quotes, company profile, news and forecasts from CNN Business.We asked three Motley Fool contributors to pick beaten-down stocks they think can deliver 5x gains by 2030. Here's why they chose CRISPR Therapeutics ( CRSP -0.74%), Ginkgo Bioworks Holdings ( DNA ...Dec 22, 2020 · On Friday, right after Thanksgiving Day, shares opened at $111.08, the stock price hovered over $120 to a new high of $124.43 before closing at $121.55 – a good 10.5% gain from the previous ... May 19, 2023 · Cash and securities were $1.9 billion as of March 31, 2023 and net loss was only $53.1 million for Q1 2023, so there is no danger of dilution in the near future. Under the Vertex Joint Development ... Find real-time UBER - Uber Technologies Inc stock quotes, company profile, news and forecasts from CNN Business.

The average SunPower stock forecast 2031 represents a 736.89% increase from the last price of $4.01999998092651. For SunPower stock forecast for 2033 (10 year), 10 predictions are offered for each month of 2033 with average SunPower stock forecast of $34.36, a high forecast of $34.5, and a low forecast of $34.21.Price target in 14 days: 89.877 USD. The best long-term & short-term CRISPR Therapeutics AG share price prognosis for 2023, 2024, 2025, 2026, 2027, 2028 with daily CRSP …Oct 26, 2023 · Price Prediction forecast forCRISPR Therapeutics to October 27, and an in-depth analysis for the week of 22 October to 28 October. Monthly forecasts CRSP for 2023 with target levels, support & resistance insights to make informed investment decisions. Find real-time EDIT - Editas Medicine Inc stock quotes, company profile, news and forecasts from CNN Business.For Vaxart stock forecast for 2033 (10 year), 10 predictions are offered for each month of 2033 with average Vaxart stock forecast of $16.43, a high forecast of $18.46, and a low forecast of $12.03. The average Vaxart stock forecast 2033 represents a 2389.86% increase from the last price of $0.660000026226044. Please, see more forecasts below.

Find real-time UBER - Uber Technologies Inc stock quotes, company profile, news and forecasts from CNN Business.

Based on short-term price targets offered by 37 analysts, the average price target for CrowdStrike Holdings comes to $201.46. The forecasts range from a low of $162.00 to a high of $245.00. The ...Apple Inc () Stock Market info Recommendations: Buy or sell Apple stock? Wall Street Stock Market & Finance report, prediction for the future: You'll find the Apple share forecasts, stock quote and buy / sell signals below.According to present data Apple's AAPL shares and potentially its market environment have been in a bullish cycle in the last 12 …Target values for the price of one Clover Health Investments share for Nov 2025. The weighted average target price per Clover Health Investments share in Nov 2025 is: 2.33. In Nov, the Positive dynamics for Momo shares will prevail with possible monthly volatility of 22.238% volatility is expected. Pessimistic target level: 2.00.Teladoc Health Stock Forecast 11-23-2023. Forecast target price for 11-23-2023: $ 17.85. Positive dynamics for Teladoc Health shares will prevail with possible volatility of 2.410%. Pessimistic target level: 17.63. Optimistic target level: 18.06.CRISPR Therapeutics Future Growth Future criteria checks 2/6 CRISPR Therapeutics is forecast to grow earnings and revenue by 46.4% and 48.2% per annum …The Trimble stock forecast is 92.58442711926 USD for 2024 November 09, Saturday; and 383.563 USD for 2028 November 09, Thursday with technical analysis. Trimble (TRMB) stock price prediction is 92.58442711926 USD.Exela Technologies, Inc. (NASDAQ:XELA) issued its quarterly earnings results on Friday, November, 5th. The company reported ($1,080.00) earnings per share for the quarter, missing the consensus estimate of ($680.00) by $400.00. The business had revenue of $279.23 million for the quarter, compared to analysts' expectations of $310 …

Stock Price Forecast According to 16 stock analysts, the average 12-month stock price forecast for CRSP stock stock is $69.88, which predicts an increase of …

Current. -$0.94. 1 Month Ago. -$1.09. 3 Months Ago. -$0.99. CRISPR Therapeutics AG analyst estimates, including CRSP earnings per share estimates and analyst recommendations.

CPRX Stock 12 Months Forecast. $23.30. (81.32% Upside) Based on 5 Wall Street analysts offering 12 month price targets for Catalyst Pharma in the last 3 months. The average price target is $23.30 with a high forecast of $27.00 and a low forecast of $15.50. The average price target represents a 81.32% change from the last price of $12.85.If we look at the company’s services, clients and according to stock market experts, 1st tdoc stock forecast 2025 can go up to 170.89 USD and 2nd tdoc stock price target is 192.75 USD in 2025, Teladoc Inc. has divided its services into 6 parts which include guidance and support, expert medical services, mental health services, platform and ...SGMO Stock 12 Months Forecast. $2.20. (514.01% Upside) Based on 7 Wall Street analysts offering 12 month price targets for Sangamo Biosciences in the last 3 months. The average price target is $2.20 with a high forecast of $3.00 and a low forecast of $1.00. The average price target represents a 514.01% change from the last price of $0.36.Stock forecasts » CRSP » 2025. CRISPR Therapeutics (CRSP) stock consensus forecasts for 2025. Last update: 06/17/2023, 02:26 AM. Brief information about CRISPR …Oct 27, 2023 · Unraveling CRISPR Therapeutics (CRSP) Stock Predictions for 2024 In the dynamic world of stock trading, precise and comprehensive forecasts are crucial. For investors eyeing CRISPR Therapeutics and its promising trajectory, we have meticulously collated insights from various analyst forecasts. We asked three Motley Fool contributors to pick beaten-down stocks they think can deliver 5x gains by 2030. Here's why they chose CRISPR Therapeutics ( CRSP -0.74%), Ginkgo Bioworks Holdings ( DNA ...Detailed Monthly CRISPR Therapeutics (CRSP) Stock Forecast and Prediction for 2025 In the fast-paced biotech industry, forecasting stock performance is a mix of art and science. As we enter 2025, the journey of CRISPR Therapeutics’ stock stands at an intriguing crossroads. 2025 Forecast: (CRSP) for 2023-2027 Updated: October 27, 2023 An Insight into CRISPR Therapeutics AG Ticker: CRSP Sector: Healthcare Closing price of the last …Cash and securities were $1.9 billion as of March 31, 2023 and net loss was only $53.1 million for Q1 2023, so there is no danger of dilution in the near future. Under the Vertex Joint Development ...CRSP : CRISPR Therapeutics AG stock forecast, predictions, and share price target for 2022, 2023 (1 year) to 2025 - 2027 (5 year) to 2030, and 2032 (10 year) with Revenue …

Monthly forecasts CRSP for 2023 with target levels, support & resistance insights to make informed investment decisions. Price Prediction forecast forCRISPR Therapeutics to November 26, and an in-depth analysis for the week of 19 November to 2 December.Next reporting date. February 22, 2024. EPS forecast (this quarter) -$1.43. Annual revenue (last year) $52.1M. Annual profit (last year) -$474.2M. Net profit margin.The Butterfly Network, Inc. stock price gained 5.01% on the last trading day (Friday, 1st Dec 2023), rising from $0.95 to $1.00. During the last trading day the stock fluctuated 7.45% from a day low at $0.94 to a day high of $1.01. The price has fallen in 6 of the last 10 days and is down by -9.91% for this period.Nov 30, 2023 · Teladoc Health Stock Forecast 12-04-2023. Forecast target price for 12-04-2023: $ 18.40. Positive dynamics for Teladoc Health shares will prevail with possible volatility of 2.308%. Pessimistic target level: 18.09. Optimistic target level: 18.52. Instagram:https://instagram. fmna stockshort tesla stockmtb bank mortgageusa dividend That has helped lift growth stocks as investors prepare their portfolios for better times. And one particular stock to benefit is biotech CRISPR Therapeutics (CRSP 0.92%). The stock has advanced ... julie zweiginvesco canada See the latest CRISPR Therapeutics AG stock price (CRSP:XNAS), related news, valuation, ... We maintain our positive outlook and fair value estimate of $119 per share. We view the stock as very ...Wall Street Stock Market & Finance report, prediction for the future: You'll find the Bionano Genomics share forecasts, stock quote and buy / sell signals below. According to present data Bionano Genomics's BNGO shares and potentially its market environment have been in bearish cycle last 12 months (if exists). tata stocks CRISPR Therapeutics AG Stock Forecast, CRSP stock price prediction. Price target in 14 days: 83.094 USD. ... CRISPR Therapeutics AG Stock Price Forecast for 2025 ...Palantir Technologies Inc - Class A (PLTR) stock price prediction is 15.953138725275 USD. The Palantir Technologies Inc - Class A stock forecast is 15.953138725275 USD for 2024 December 01, Sunday with technical analysis.Find real-time CRSP - CRISPR Therapeutics AG stock quotes, company profile, news and forecasts from CNN Business.